Literature DB >> 11505069

Trauma inhibits erythroid burst-forming unit and granulocyte-monocyte colony-forming unit growth through the production of TGF-beta1 by bone marrow stroma.

J C Wu1, D H Livingston, C J Hauser, E A Deitch, P Rameshwar.   

Abstract

OBJECTIVE: To examine the effect of trauma plasma on clonogenic progenitor cultures. SUMMARY BACKGROUND DATA: Severely injured trauma patients often experience altered hematopoietic functions, manifested by an increased susceptibility to infection and the development of a persistent anemia. Experimental and clinical data suggest that trauma results in the release of cytokines into the plasma that have hematopoietic regulatory function, but few studies have examined human bone marrow.
METHODS: Plasma was obtained from 42 severely injured patients admitted to the surgical intensive care unit from days 1 to 15 after injury. Bone marrow and normal plasma were obtained from volunteers. Bone marrow mononuclear cells were isolated and plated for granulocyte-monocyte colony-forming unit (CFU-GM) and erythroid burst-forming unit (BFU-E) growth. Parallel cultures were incubated with 2% (v/v) trauma or normal plasma. Additional cultures were plated with neutralizing concentrations of antibodies to transforming growth factor (TGF)-beta1 and MIP-1alpha. Circulating plasma TGF-beta1 was determined by bioassay. mRNA from bone marrow stromal cultures was extracted and probed for TGF-beta1 and macrophage inflammatory protein (MIP)-1alpha.
RESULTS: Trauma plasma suppressed CFU-GM and BFU-E colony growth by 40% to 60% at all time periods after injury compared with cultures incubated with normal plasma. Using a noncontact culture system, the authors showed that this inhibition of BFU-E and CFU-GM colony growth was mediated by bone marrow stroma. The inhibition appeared to be due to soluble plasma-induced bone marrow stromal products that did not require direct cell-cell contact. The addition of anti-TGF-beta1 antibodies reversed the suppressive effect of trauma plasma on CFU-GM and BFU-E colony growth during the early but not late time points after injury. Trauma but not normal plasma induced TGF-beta1 mRNA in bone marrow stroma.
CONCLUSIONS: Trauma plasma inhibits bone marrow BFU-E and CFU-GM colony growth for up to 2 weeks after injury. This inhibition is mediated through the interaction of trauma plasma with bone marrow stroma. TGF-beta1 production by bone marrow stroma appears to plays an important role in the early but not late bone marrow suppression after injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11505069      PMCID: PMC1422010          DOI: 10.1097/00000658-200108000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

Review 1.  The molecular control of blood cell development.

Authors:  L Sachs
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

2.  Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.

Authors:  H L Corwin; A Gettinger; R M Rodriguez; R G Pearl; K D Gubler; C Enny; T Colton; M J Corwin
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

3.  A serial study of the erythropoietic response to thermal injury.

Authors:  E A Deitch; K M Sittig
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

4.  Inadequate granulopoiesis after major torso trauma: a hematopoietic regulatory paradox.

Authors:  F A Moore; V M Peterson; E E Moore; C Rundus; R Poggetti
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

5.  Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury.

Authors:  P O Iversen; N Hjeltnes; B Holm; T Flatebo; I Strom-Gundersen; W Ronning; J Stanghelle; H B Benestad
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

6.  Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow.

Authors:  K Jacobsen; D G Osmond
Journal:  Eur J Immunol       Date:  1990-11       Impact factor: 5.532

7.  Bone marrow failure after hemorrhagic shock.

Authors:  D H Livingston; P S Gentile; M A Malangoni
Journal:  Circ Shock       Date:  1990-03

8.  Effects of hypoxia on granulocytic-monocytic progenitors in rats. Role of bone marrow stroma.

Authors:  R Taneja; P Rameshwar; J Upperman; M T Wang; D H Livingston
Journal:  Am J Hematol       Date:  2000-05       Impact factor: 10.047

9.  Interferon-gamma reverses bone marrow inhibition following hemorrhagic shock.

Authors:  D H Livingston
Journal:  Arch Surg       Date:  1991-01

10.  Regulation of granulopoiesis following severe thermal injury.

Authors:  V Peterson; J Hansbrough; C Buerk; C Rundus; S Wallner; H Smith; W A Robinson
Journal:  J Trauma       Date:  1983-01
View more
  17 in total

1.  Does selective beta-1 blockade provide bone marrow protection after trauma/hemorrhagic shock?

Authors:  Latha V Pasupuleti; Kristin M Cook; Ziad C Sifri; Srinath Kotamarti; Gabriel M Calderon; Walter D Alzate; David H Livingston; Alicia M Mohr
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

2.  Local transplantation of bone marrow concentrated granulocytes precursors can cure without antibiotics infected nonunion of polytraumatic patients in absence of bone defect.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat-Lachaniette
Journal:  Int Orthop       Date:  2016-03-01       Impact factor: 3.075

3.  Persistent injury-associated anemia: the role of the bone marrow microenvironment.

Authors:  Jessica K Millar; Kolenkode B Kannan; Tyler J Loftus; Ines G Alamo; Jessica Plazas; Philip A Efron; Alicia M Mohr
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

4.  Clonidine reduces norepinephrine and improves bone marrow function in a rodent model of lung contusion, hemorrhagic shock, and chronic stress.

Authors:  Ines G Alamo; Kolenkode B Kannan; Harry Ramos; Tyler J Loftus; Philip A Efron; Alicia M Mohr
Journal:  Surgery       Date:  2016-10-11       Impact factor: 3.982

5.  Systemic Regulation of Bone Marrow Stromal Cytokines After Severe Trauma.

Authors:  Elizabeth S Miller; Tyler J Loftus; Kolenkode B Kannan; Jessica M Plazas; Philip A Efron; Alicia M Mohr
Journal:  J Surg Res       Date:  2019-06-14       Impact factor: 2.192

6.  Mesenchymal stem cells reverse bone marrow dysfunction following injury and stress.

Authors:  Amy V Gore; Letitia E Bible; David H Livingston; Alicia M Mohr; Ziad C Sifri
Journal:  J Trauma Acute Care Surg       Date:  2015-10       Impact factor: 3.313

7.  Persistent inflammation and anemia among critically ill septic patients.

Authors:  Tyler J Loftus; Juan C Mira; Julie A Stortz; Tezcan Ozrazgat-Baslanti; Gabriella L Ghita; Zhongkai Wang; Babette A Brumback; Ricardo F Ungaro; Azra Bihorac; Christiaan Leeuwenburgh; Frederick A Moore; Lyle L Moldawer; Scott C Brakenridge; Philip A Efron; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2019-02       Impact factor: 3.313

8.  Is the sympathetic system involved in shock-induced gut and lung injury?

Authors:  Gregg M Baranski; Ziad C Sifri; Kristen M Cook; Walter D Alzate; David H Livingston; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2012-08       Impact factor: 3.313

9.  Bone marrow failure following severe injury in humans.

Authors:  David H Livingston; Devashish Anjaria; Jonathan Wu; Carl J Hauser; Victor Chang; Edwin A Deitch; Pranela Rameshwar
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

10.  The Postinjury Inflammatory State and the Bone Marrow Response to Anemia.

Authors:  Tyler J Loftus; Juan C Mira; Elizabeth S Miller; Kolenkode B Kannan; Jessica M Plazas; Daniel Delitto; Julie A Stortz; Jennifer E Hagen; Hari K Parvataneni; Kalia K Sadasivan; Scott C Brakenridge; Frederick A Moore; Lyle L Moldawer; Philip A Efron; Alicia M Mohr
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.